Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.85 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | GAA | P10253 | 1/20 | 0.64 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.64 |
| ▸ | HTT | P42858 | 1/20 | 0.64 |
| ▸ | CES2 | O00748 | 1/20 | 0.61 |
| ▸ | CES1 | P23141 | 1/20 | 0.61 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.52 |
| ▸ | PAM | P19021 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenylacetic Acid SCHEMBL18210528 | 0.95 | AKR1B1 (0.85) | AKR1B1TSHRABCC4LMNAGAA | |
| Phenylacetic Acid SCHEMBL2417581 | 0.95 | AKR1B1 (0.85) | AKR1B1TSHRABCC4LMNAGAA | |
| Phenylacetic Acid SCHEMBL28102451 | 0.95 | AKR1B1 (0.85) | AKR1B1TSHRABCC4LMNAGAA | |
| Phenylacetic Acid SCHEMBL27287946 | 0.93 | AKR1B1 (0.81) | AKR1B1TSHRABCC4LMNAGAA | |
| Phenylacetic Acid SCHEMBL245917 | 0.92 | AKR1B1 (0.90) | AKR1B1TSHRABCC4LMNAGAA | |
| Phenylacetic Acid SCHEMBL1260881 | 0.92 | AKR1B1 (0.90) | AKR1B1TSHRABCC4LMNAGAA | |
| Phenylacetic Acid SCHEMBL13618842 | 0.92 | AKR1B1 (1.00) | AKR1B1TSHRABCC4LMNAGAA | |
| Phenylacetic Acid SCHEMBL1459 | 0.92 | AKR1B1 (1.00) | AKR1B1TSHRABCC4LMNAGAA | |
| Phenylacetic Acid SCHEMBL1330777 | 0.92 | AKR1B1 (1.00) | AKR1B1TSHRABCC4LMNAGAA | |
| Phenylacetic Acid SCHEMBL9449909 | 0.92 | AKR1B1 (1.00) | AKR1B1TSHRABCC4LMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113413456-A | Method for producing recombinant peptides and resulting peptides | OVB(爱尔兰)有限公司 | 2021-09-21 | — | — | CN | disclosed |
| CN-104662034-B | Method for producing recombinant peptides and resulting peptides | "IVIX"有限公司 | 2021-05-11 | — | — | CN | disclosed |
| US-20170158735-A1 | METHOD FOR PRODUCING A RECOMBINANT PEPTIDE AND RESULTANT PEPTIDE | "IVIX" LTD. (RU) | 2017-06-08 | — | — | US | disclosed |
| US-9409947-B2 | Method for producing a recombinant peptide and resultant peptide | “IVIX” LTD. (RU) | 2016-08-09 | — | — | US | disclosed |
| CN-104662034-A | Method for producing recombinant peptides and resulting peptides | OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTIYU IVIX | 2015-05-27 | — | — | CN | disclosed |
| US-20150111837-A1 | Method for Producing a Recombinant Peptide and Resultant Peptide | "IVIX" LTD. (RU) | 2015-04-23 | — | — | US | disclosed |
| CN-1328369-C | Preparing pravastatin | INST DRUG RES LTD (HU) | 2007-07-25 | — | — | CN | disclosed |
| US-20060281155-A1 | Microbial process for preparing pravastatin | JEKKEL ANTONIA | 2006-12-14 | — | — | US | disclosed |
| CN-1814766-A | Preparing pravastatin | INST DRUG RES LTD (HU) | 2006-08-09 | — | — | CN | disclosed |
| CN-1260344-C | Culture of microorganisms | INST DRUG RES LTD (HU) | 2006-06-21 | — | — | CN | disclosed |
| US-6682913-B1 | CULTIVATING A STRAIN OF MORTIERELLA MACULATA FILAMENTOUS MOLD SPECIES THAT IS ABLE TO 6 BETA -HYDROXYLATE AN INTERMEDIATE | INSTITUTE FOR DRUG RESEARCH LTD. (HU) | 2004-01-27 | — | — | US | disclosed |
| US-20030207413-A1 | Microbial process for preparing pravastatin | JEKKEL ANTONIA (HU) | 2003-11-06 | — | — | US | disclosed |
| EP-1198448-A4 | MICROBIAL PROCESS FOR PREPARING PRAVASTATIN | IVAX CORP (US) | 2003-05-28 | — | — | EP | disclosed |
| CN-1399686-A | Hydroxylation of compactin to pravastatin by micromonospora | IVAX PHARMA INST CO (HU) | 2003-02-26 | — | — | CN | disclosed |
| US-20020081675-A1 | Microbial process for preparing pravastatin | JEKKEL ANTONIA (HU) | 2002-06-27 | — | — | US | disclosed |
| CN-1347400-A | Microbial process for the preparation of pravastatin | INST DRUG RES LTD (HU) | 2002-05-01 | — | — | CN | disclosed |
| EP-1198448-A2 | MICROBIAL PROCESS FOR PREPARING PRAVASTATIN | Ivax Corporation (US) | 2002-04-24 | — | — | EP | disclosed |
| EP-1154979-A1 | MICROBIAL PROCESS FOR PREPARING PRAVASTATIN | Institute for Drug Research Ltd. (HU) | 2001-11-21 | — | — | EP | disclosed |
| WO-2001003647-A2 | MICROBIAL PROCESS FOR PREPARING PRAVASTATIN | IVAX CORPORATION (US) | 2001-01-18 | — | — | WO | disclosed |
| WO-2000046175-A1 | MICROBIAL PROCESS FOR PREPARING PRAVASTATIN | INSTITUTE FOR DRUG RESEARCH LTD. (HU) | 2000-08-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030207413-A1 | Microbial process for preparing pravastatin | CYP11B2, CYP51A1, CYP11B1 | AKR1B1 126/4885TSHR 4435/4885ABCC4 1734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.